Truveta Uses Real-Time EHR Data to Flag Rising Gaps in Childhood MMR Vaccination

New updates have been reported about Truveta.

Truveta has released new peer-reviewed research in JAMA Network Open that strengthens its positioning as a real-world data and analytics platform for population health, while also highlighting a growing public health risk with potential policy and payer implications. Using de-identified electronic health records from Truveta Data—covering over 120 million individuals nationwide—the company’s research arm analyzed vaccination patterns for 321,743 children born between 2017 and 2023 with regular access to care, and found that on-time receipt of the first measles, mumps, and rubella (MMR) dose has declined since the COVID-19 pandemic. The study shows that delays in standard 2- and 4‑month infant vaccines strongly predict later failure to receive MMR by age two, with late early-series vaccinations associated with a six- to seven-fold increase in the likelihood of missing MMR entirely. These findings provide a scalable, EHR-based early warning signal that health systems, payers, and public health agencies can use to target outreach before immunization gaps widen.

For Truveta, the publication demonstrates both the analytical depth and operational timeliness of its platform, underscoring how its data can be used to monitor vaccine coverage and emerging disease risks in near real time. Company researchers emphasized that early identification of vaccination delays can help clinicians intervene sooner with evidence-based, empathetic communication, an increasingly important capability amid rising misinformation and evolving federal vaccine policies. With measles cases surging in 2025 and outbreaks reported across multiple regions, the study illustrates a concrete use case for Truveta’s data in supporting regulatory-grade evidence, guiding resource allocation, and informing value-based care strategies that depend on preventive measures. Funded by Truveta Inc., the work reinforces the company’s strategic narrative as a critical infrastructure provider for health systems seeking to derive actionable insights from EHR data, and is likely to support deeper engagement with providers, payers, and public health stakeholders who need precise, up-to-date population-level intelligence on pediatric vaccination trends.